Biofuels at the Tipping Point

Biofuels at the Tipping Point

May 22, 2012

While the "food versus fuel" debate has grabbed headlines, biofuels technology worldwide has been accelerating down the learning curve and is at a "tipping point" for commercialization.

AeroShot Delivers the Taste of Chocolate Without the Calories

AeroShot Delivers the Taste of Chocolate Without the Calories

May 8, 2012

AeroDesigns, Inc. announces the U.S. launch of its zero-calorie, aerodynamic chocolate product invented by Harvard professor David Edwards

LS9 Announces Florida Plant Grand Opening and Receives $4.5 million from Florida Opportunity Fund

LS9 Announces Florida Plant Grand Opening and Receives $4.5 million from Florida Opportunity Fund

May 14, 2012

South san francisco, CA (May 14, 2012) – LS9, Inc., a technology leader in the development of renewable and sustainable products, today announced an investment from the Florida Opportunity Fund's (FOF) Clean Energy Investment Program, and the Grand Opening plans for its facility in Okeechobee, Florida.

Helicos BioSciences Corporation Settles its Patent Litigation Against Pacific Biosciences, Inc.

Helicos BioSciences Corporation Settles its Patent Litigation Against Pacific Biosciences, Inc.

May 14, 2012

Litigation Against Illumina, Life Technologies Continues

Affinnova Announces Record Sales

Affinnova Announces Record Sales

May 17, 2012

WALTHAM, Mass., May 17, 2012 (BUSINESS WIRE) -- Affinnova, Inc., the global leader in innovation software and services, has announced record sales for the prior twelve months ending March, 2012. Total sales increased 43% compared to the previous 12-month period. Non-U.S. sales rose to 18% of the business overall, as Affinnova has aggressively expanded its operations in Europe, hiring staff in the United Kingdom, France and Germany.

BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Mayo Medical Laboratories

BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Mayo Medical Laboratories

May 14, 2012

WALTHAM, Mass., May 14, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Mayo Medical Laboratory (Mayo) now offers galectin-3 testing services to its laboratory customers and physicians. Mayo will offer the BGM Galectin-3TM test, which was cleared by the U.S.

BG Medicine Announces Publication of First Study on Use of Galectin-3 inSelection of Drug Therapy in Heart Failure

BG Medicine Announces Publication of First Study on Use of Galectin-3 inSelection of Drug Therapy in Heart Failure

May 14, 2012

WALTHAM, Mass., May 14, 2012 (GlobeNewswire via COMTEX) -- BG Medicine, Inc.

Eleven Biotherapeutics Secures $20 Million and Expands Series A Financing

Eleven Biotherapeutics Secures $20 Million and Expands Series A Financing

May 8, 2012

Company to Advance its lead Drug Candidate, EBI-005, into Clinic Development for Dry Eye Disease

US Scientists Who Mean Business

US Scientists Who Mean Business

May 6, 2012

 

Vaccine Could Stop Nicotine from Reaching the Brain

Vaccine Could Stop Nicotine from Reaching the Brain

May 1, 2012

The new antismoking technique uses nanoparticles to trigger an immune response.

By Conor Myhrvold